Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration

Hepatocellular carcinoma (HCC) is a development of severe liver disease frequently due to HBV and/or HCV infection. The aim of this retrospective study was to evaluate the development of HCC in patients with HBV-HCV chronic infection compared with patients with single HBV or HCV infection and the vi...

Full description

Bibliographic Details
Main Authors: Rosa Zampino, M.D. Ph.D., Maria A. Pisaturo, Grazia Cirillo, Aldo Marrone, Margherita Macera, Luca Rinaldi, Maria Stanzione, Emanuele Durante-Mangoni, Ivan Gentile, Evangelista Sagnelli, Giuseppe Signoriello, Emanuele Miraglia del Giudice, Luigi E. Adinolfi, Nicola Coppola
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119308038
_version_ 1819012230318915584
author Rosa Zampino, M.D. Ph.D.
Maria A. Pisaturo
Grazia Cirillo
Aldo Marrone
Margherita Macera
Luca Rinaldi
Maria Stanzione
Emanuele Durante-Mangoni
Ivan Gentile
Evangelista Sagnelli
Giuseppe Signoriello
Emanuele Miraglia del Giudice
Luigi E. Adinolfi
Nicola Coppola
author_facet Rosa Zampino, M.D. Ph.D.
Maria A. Pisaturo
Grazia Cirillo
Aldo Marrone
Margherita Macera
Luca Rinaldi
Maria Stanzione
Emanuele Durante-Mangoni
Ivan Gentile
Evangelista Sagnelli
Giuseppe Signoriello
Emanuele Miraglia del Giudice
Luigi E. Adinolfi
Nicola Coppola
author_sort Rosa Zampino, M.D. Ph.D.
collection DOAJ
description Hepatocellular carcinoma (HCC) is a development of severe liver disease frequently due to HBV and/or HCV infection. The aim of this retrospective study was to evaluate the development of HCC in patients with HBV-HCV chronic infection compared with patients with single HBV or HCV infection and the viral and host factors correlated to HCC in co-infected patients. We studied 268 patients with histology proven chronic hepatitis: 56 had HBV-HCV co-infection (HBV-HCV group), 46 had HBV infection (HBV group) and 166 had HCV infection (HCV group). Patients were followed up for at least 3 years. Viral and host factors were studied. HCC was more frequent in HBV-HCV group (14%) compared with HBV (2%, p = 0.006) and HCV monoinfected (4%, p = 0.006). The Mantel-Haenszel test used to investigate the relationship between HBV-HCV co-infection and development of HCC indicated an association between development of HCC and HBV-HCV co-infection (p < 0.001). In the HBV-HCV group, patients with HCC were significantly older (p = 0.000), had longer disease duration (p = 0.001), higher blood glucose levels (p = 0.001), lower levels of steatosis (p = 0.02), higher levels of fibrosis (p = 0.000), higher HCV RNA (p = 0.01) than those without HCC. ALT, lipid profile, PNPLA3 variant distribution and HBV viral load did not differ among co-infected patients with or without HCC. In conclusion HCC was more frequent in our patients with HBV-HCV co-infection, than in those with HBV or HCV mono-infection; possible associated risk factors for HCC development seem a long duration of disease, high levels of fibrosis and carbohydrate intolerance.
first_indexed 2024-12-21T01:40:45Z
format Article
id doaj.art-12b54a191c464990b978a9c736e0832c
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-12-21T01:40:45Z
publishDate 2015-01-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-12b54a191c464990b978a9c736e0832c2022-12-21T19:20:10ZengElsevierAnnals of Hepatology1665-26812015-01-011417582Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease durationRosa Zampino, M.D. Ph.D.0Maria A. Pisaturo1Grazia Cirillo2Aldo Marrone3Margherita Macera4Luca Rinaldi5Maria Stanzione6Emanuele Durante-Mangoni7Ivan Gentile8Evangelista Sagnelli9Giuseppe Signoriello10Emanuele Miraglia del Giudice11Luigi E. Adinolfi12Nicola Coppola13Internal Medicine and Hepatology, Italy; Correspondence and reprint request:Department of Mental Health and Public Medicine, Section of Infectious Diseases, ItalyDepartment of Pediatrics, ItalyInternal Medicine and Hepatology, ItalyDepartment of Clinical and Experimental Medicine and Surgery F. Magrassi e A. Lanzara, ItalyInternal Medicine and Hepatology, ItalyDepartment of Clinical and Experimental Medicine and Surgery F. Magrassi e A. Lanzara, ItalyInternal Medicine Monaldi Hospital, ItalySecond University of Naples; Department of Clinical Medicine and Surgery-University of Naples Federico, ItalyDepartment of Mental Health and Public Medicine, Section of Infectious Diseases, ItalyDepartment of Mental Health and Public Medicine, Section of Infectious Diseases, ItalyDepartment of Pediatrics, ItalyInternal Medicine and Hepatology, ItalyDepartment of Mental Health and Public Medicine, Section of Infectious Diseases, ItalyHepatocellular carcinoma (HCC) is a development of severe liver disease frequently due to HBV and/or HCV infection. The aim of this retrospective study was to evaluate the development of HCC in patients with HBV-HCV chronic infection compared with patients with single HBV or HCV infection and the viral and host factors correlated to HCC in co-infected patients. We studied 268 patients with histology proven chronic hepatitis: 56 had HBV-HCV co-infection (HBV-HCV group), 46 had HBV infection (HBV group) and 166 had HCV infection (HCV group). Patients were followed up for at least 3 years. Viral and host factors were studied. HCC was more frequent in HBV-HCV group (14%) compared with HBV (2%, p = 0.006) and HCV monoinfected (4%, p = 0.006). The Mantel-Haenszel test used to investigate the relationship between HBV-HCV co-infection and development of HCC indicated an association between development of HCC and HBV-HCV co-infection (p < 0.001). In the HBV-HCV group, patients with HCC were significantly older (p = 0.000), had longer disease duration (p = 0.001), higher blood glucose levels (p = 0.001), lower levels of steatosis (p = 0.02), higher levels of fibrosis (p = 0.000), higher HCV RNA (p = 0.01) than those without HCC. ALT, lipid profile, PNPLA3 variant distribution and HBV viral load did not differ among co-infected patients with or without HCC. In conclusion HCC was more frequent in our patients with HBV-HCV co-infection, than in those with HBV or HCV mono-infection; possible associated risk factors for HCC development seem a long duration of disease, high levels of fibrosis and carbohydrate intolerance.http://www.sciencedirect.com/science/article/pii/S1665268119308038HCCRisk factorsChronic hepatitis
spellingShingle Rosa Zampino, M.D. Ph.D.
Maria A. Pisaturo
Grazia Cirillo
Aldo Marrone
Margherita Macera
Luca Rinaldi
Maria Stanzione
Emanuele Durante-Mangoni
Ivan Gentile
Evangelista Sagnelli
Giuseppe Signoriello
Emanuele Miraglia del Giudice
Luigi E. Adinolfi
Nicola Coppola
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
Annals of Hepatology
HCC
Risk factors
Chronic hepatitis
title Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
title_full Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
title_fullStr Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
title_full_unstemmed Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
title_short Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
title_sort hepatocellular carcinoma in chronic hbv hcv co infection is correlated to fibrosis and disease duration
topic HCC
Risk factors
Chronic hepatitis
url http://www.sciencedirect.com/science/article/pii/S1665268119308038
work_keys_str_mv AT rosazampinomdphd hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT mariaapisaturo hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT graziacirillo hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT aldomarrone hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT margheritamacera hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT lucarinaldi hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT mariastanzione hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT emanueledurantemangoni hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT ivangentile hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT evangelistasagnelli hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT giuseppesignoriello hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT emanuelemiragliadelgiudice hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT luigieadinolfi hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration
AT nicolacoppola hepatocellularcarcinomainchronichbvhcvcoinfectioniscorrelatedtofibrosisanddiseaseduration